Mitochondria - Nitric oxide signalling
pathway: the downstream role of AMPK
Our laboratory has characterized in detail
the interaction between NO and cytochrome c oxidase and I am currently
studying the signalling consequences of this interaction. Since
the competition between NO and O2 in the mitochondria becomes relevant
at low O2 concentrations, we have shown that when human vascular
endothelial cells are exposed to physiological levels of O2 (i.e.
3%), the AMP-activated protein kinase alpha1 is activated by a mechanism
independent of energy changes, but dependent on mitochondrial reactive
oxygen species (mtROS). One of our current hypotheses is that AMPK
alpha1, activated by mtROS, participates in the orchestration of cellular
defence mechanisms, mainly by modulating gene expression.
We have generated several genetic models (eg
eNOS-/- and AMPK alpha1 -/-) to study the downstream consequences of
this signalling pathway, exploiting the benefits of reverse genetics.
A second core area of our research is to investigate the molecular
mechanisms involved in the transduction of the mtROS signal in the
activation of this pathway.
Selected
publications
1. Sergio L Colombo and Salvador Moncada
(2009) – “AMPKalpha1 regulates the antioxidant defence
of the vascular endothelial cells”. Biochem J Signal. 421:163-169.
2. Quintero M, Colombo S, Godfrey A and
Moncada S (2006) Mitochondria as signaling organelles in the
vascular endothelium. Proc Natl Acad Sci U S A 103: 5379-5384.
3. Palacios-Callender M, Quintero
M, Hollis VS, Springett RJ, Moncada S. (2004) Endogenous NO regulates
superoxide production at low oxygen concentrations by modifying
the redox state of cytochrome c oxidase. Proc Natl Acad Sci U S
A 101:7630-7635.
Academic Career
2004-present - Wolfson
Inst. Biomedical Research, University College London, London - UK.
Senior Research Postdoc.
2002-2004 - GlaxoSmithKline,
CEDD of Neurology, Harlow - UK. Marie Curie EU Postdoc.
1998-2002 - Biological
Sciences Dept, Louisiana State University. Baton Rouge – USA.
Postdoc
1993-1998 - National
University of Rosario, CEFOBI Rosario, Argentina. PhD.
Funding
Wellcome Trust
Figure 1:
Proposed model of the NO/mitochondria signalling pathway.